Management Team

The Nometics Inc. founding team has experience in the areas required for the successful development of cancer therapeutics.

Name	Title
Robert Bender	Chairman
David Barnes, M.D.	CMO, V.P. Regulatory Affairs
Fred Saad M.D.	Chair, Urology Clinical Advisory Board
Doug Cowart, D.Pharm.	V.P. Pharmacology
Douglas McNair, M.D., Ph.D.	V.P. Trial Design & Biostatistics